Race-free eGFR
Kidney function equations without a race coefficient.
Papers per year
Each bar is 12 months; the last one ends 17 Oct 2026. New trials in the same years: 5, 8, 15, 13, 27.
All papers from the last 12 months
151 papers (18 Oct 2025 – 17 Oct 2026), newest first. Loading the full list…
- Blood lead exposure, renal hyperfiltration, and accelerated kidney function decline among people living with HIV in northern Tanzania: A longitudinal cohort studyToxicol Rep2026 DecPMID 42861259
- Effects of Lithium Treatment on Renal Function in Bipolar Disorder: A Retrospective Cohort StudyPsychiatry Res2026 DecPMID 42810282
- Comprehensive trends in Chronic Kidney Disease prevalence and comorbidities across eGFR and albuminuria categories: a 20-year analysis of NHANES dataRen Fail2026 DecPMID 42736589
- [Correlation between albuminuria and glycated haemoglobin in diabetic patients with an eGFR ≥ 60 mL/min/1.73 m²]Ann Biol Clin (Paris)2026 Oct 12PMID 42862638
- Association of chronic kidney disease with major cardiovascular outcomes following lower extremity endovascular revascularizationPostgrad Med2026 Oct 12PMID 42862007
- Integrative bioinformatics analysis of Lianmei granules in diabetic nephropathy: Epidemiological and molecular insightsMedicine (Baltimore)2026 Oct 9PMID 42854049
- Race-Neutral Glomerular Filtration Rate Projected to Increase Kidney Transplantation for Black Patients: Initial Policy Effects at a Single CenterClin Transplant2026 OctPMID 42867480
- Multiple Sclerosis Misdiagnosis in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy: A Genotype-Misphenotype StudyNeurol Genet2026 OctPMID 42689243
- Disparities in Epidermal Growth Factor Receptor Mutation Testing for Non-Small Cell Lung Cancer: Insights From the National Cancer DatabaseJ Surg Res2026 OctPMID 42600435
- An observational study of patients receiving delayed-release budesonide (Nefecon) for immunoglobulin A nephropathy in the United States: A case series of Asian-American patientsClin Nephrol2026 OctPMID 42596753
More nephrology trends
All specialties →Complement inhibitors in kidney disease
Iptacopan, avacopan and other complement inhibitors in glomerular disease.
Key point: Complement inhibitors had no overall effectiveness or safety advantage over plasma therapy in atypical hemolytic uremic syndrome, except lower relapse rates.
APOL1 kidney disease
Kidney disease linked to APOL1 gene variants.
Home dialysis
Home haemodialysis and peritoneal dialysis.
Key point: Core interventions to reduce PD-related infections focus on surveillance, standardized staff and patient training, infection prevention assessments, and antimicrobial prophylaxis.
HIF-PH inhibitors for anaemia
Oral drugs such as roxadustat for anaemia of kidney disease.
Key point: HIF-PHIs such as roxadustat are reserved for non-dialysis CKD when erythropoiesis-stimulating agents are unsuitable, given potential risks and limited long-term data.
Pig kidney xenotransplantation
Transplanting genetically modified pig kidneys into humans.
Potassium binders
Patiromer and sodium zirconium cyclosilicate for hyperkalaemia.
Key point: In type 2 diabetes with hyperkalemia, sodium zirconium cyclosilicate did not demonstrate noninferiority to potassium-restricted diet for achieving normokalemia.
Too many papers to read?
PubDaily picks the ones that matter in your specialty and summarises them, about 10 minutes a week.
How these numbers are counted
PubMed query, searched in titles and abstracts by publication date:
eGFR[tiab] AND (race[tiab] OR "race-free"[tiab] OR "CKD-EPI 2021"[tiab])Trials: ClinicalTrials.gov studies first submitted in each 12-month window that match the same terms. A query can miss synonyms or catch unrelated papers, so treat counts as approximate.